A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

By Alsner Jan   Jensen Vibeke   Kyndi Marianne   Vrou Offersen Birgitte   Vu Phuong   Børresen-Dale Anne-Lise   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 600-607

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

By Grøndahl-Hansen J.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 153-163

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

By Witzel Isabell   Milde-Langosch Karin   Wirtz Ralph   Roth Claudia   Ihnen Maike   Mahner Sven   Zu Eulenburg Christine   Jänicke Fritz   Müller Volkmar  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1709-1718

Springer Publishing Company

Access to resources Recommend Favorite

Differential Gene Expression of BRCA1, ERBB2 and TP53 Biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 519-525

Bentham Science Publishers

Access to resources Recommend Favorite